我武生物：控股股东计划以大宗交易方式减持不超过总股本的0.86%

Group 1 - The controlling shareholder of the company plans to reduce its stake by up to 4.5 million shares through block trading, representing 0.86% of the total share capital [1] - The company's director and deputy general manager, Zhang Lu, intends to sell up to 300,000 shares through centralized bidding, accounting for 0.06% of the total share capital [1] - The reduction plan will not lead to a change in the company's control or affect its governance structure and ongoing operations [1]